We are live on ! Find out more
TSW

Thompson Siegel & Walmsley Portfolio holdings

AUM $5.7B
1-Year Est. Return 6.69%
This Fund
S&P 500
This Quarter Est. Return
+4.99%
1 Year Est. Return
+6.69%
3 Year Est. Return
+28.78%
5 Year Est. Return
+35.85%
10 Year Est. Return
+92.81%
AUM
$7.3B
AUM Growth
+$297M
Cap. Flow
-$50.3M
Cap. Flow %
-0.69%
Top 10 Hldgs %
17.43%
Holding
817
New
58
Increased
143
Reduced
218
Closed
72

Top Buys

Rank Stock Value
1
OGN icon
Organon & Co
OGN
+$86.7M
2
GPK icon
Graphic Packaging
GPK
+$49.8M
3
FLEX icon
Flex
FLEX
+$46.9M
4
ORI icon
Old Republic International
ORI
+$46M
5
NVR icon
NVR
NVR
+$40.7M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$92.1M
2
BG icon
Bunge Global
BG
+$50.3M
3
LDOS icon
Leidos
LDOS
+$39.3M
4
FLIR
FLIR Systems, Inc. (DE) Common Stock
FLIR
+$38.5M
5
VYX icon
NCR Voyix
VYX
+$34.8M

Sector Composition

Rank Sector Weight
1 Financials 17.68%
2 Technology 12.23%
3 Healthcare 9.96%
4 Consumer Discretionary 9.73%
5 Utilities 9.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRAH
501
DELISTED
PRA Health Sciences, Inc.
PRAH
$45K ﹤0.01%
270
– –
NAV
502
DELISTED
Navistar International
NAV
$45K ﹤0.01%
1,020
– –
CSV icon
503
Carriage Services
CSV
$641M
$44K ﹤0.01%
1,200
– –
MOD icon
504
Modine Manufacturing
MOD
$10.7B
$44K ﹤0.01%
2,650
– –
SUM
505
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$44K ﹤0.01%
1,271
– –
FOE
506
DELISTED
Ferro Corporation
FOE
$44K ﹤0.01%
2,030
– –
FCX icon
507
Freeport-McMoran
FCX
$90B
$43K ﹤0.01%
+1,170
New +$45.6K
MTB icon
508
M&T Bank
MTB
$35.7B
$43K ﹤0.01%
293
– –
TG icon
509
Tredegar Corp
TG
$265M
$43K ﹤0.01%
3,125
– –
XRAY icon
510
Dentsply Sirona
XRAY
$2.68B
$43K ﹤0.01%
678
– –
ELV icon
511
Elevance Health
ELV
$81.5B
$42K ﹤0.01%
110
-25
-19% -$9.55K
INCY icon
512
Incyte
INCY
$24.2B
$42K ﹤0.01%
500
+250
+100% +$20.8K
PATK icon
513
Patrick Industries
PATK
$2.74B
$42K ﹤0.01%
855
– –
SHOO icon
514
Steven Madden
SHOO
$3.37B
$42K ﹤0.01%
950
+200
+27% +$8.25K
TME icon
515
Tencent Music
TME
$15.5B
$42K ﹤0.01%
+2,700
New +$44.7K
VRS
516
DELISTED
Verso Corporation
VRS
$42K ﹤0.01%
2,350
– –
CNMD icon
517
CONMED
CNMD
$1.39B
$41K ﹤0.01%
300
– –
FIX icon
518
Comfort Systems
FIX
$60.9B
$41K ﹤0.01%
525
– –
INGR icon
519
Ingredion
INGR
$6.27B
$41K ﹤0.01%
452
-330,080
-100% -$30.8M
MYRG icon
520
MYR Group
MYRG
$5.19B
$41K ﹤0.01%
450
– –
QRVO icon
521
Qorvo
QRVO
$7.99B
$40K ﹤0.01%
206
-15
-7% -$2.77K
ZBH icon
522
Zimmer Biomet
ZBH
$18.2B
$40K ﹤0.01%
259
– –
KNL
523
DELISTED
Knoll, Inc.
KNL
$40K ﹤0.01%
1,550
– –
AZTA icon
524
Azenta
AZTA
$1.3B
$38K ﹤0.01%
400
– –
BOOT icon
525
Boot Barn
BOOT
$4.51B
$38K ﹤0.01%
450
– –
19 20
21
22 23

Similar funds

PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.66B AUM 27.45% 1-Year Est. Return
HW
Hancock Whitney Gulfport, Mississippi $5.75B AUM 24.3% 1-Year Est. Return
AAM
Alphadyne Asset Management New York $5.76B AUM 22.07% 1-Year Est. Return

Thompson Siegel & Walmsley's Q2 2021 Portfolio in Review

As of Q2 2021, Thompson Siegel & Walmsley held 817 positions worth $7.3B, up 4.2% from $7.01B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Thompson Siegel & Walmsley's Q2 2021 filing shows 58 new, 143 increased, 218 reduced and 72 closed positions. Its largest new stake was Organon & Co: 2,634,306 shares worth $79.7M. The largest sale was Alexion Pharmaceuticals, an estimated $92.1M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.

  • Thompson Siegel & Walmsley's largest Q2 2021 buy was Organon & Co: 2,634,306 shares worth $79.7M.
  • Thompson Siegel & Walmsley added most to Graphic Packaging in Q2 2021, an estimated $49.8M increase.
  • Thompson Siegel & Walmsley's biggest Q2 2021 reduction was Alexion Pharmaceuticals, cutting an estimated $92.1M.
  • Thompson Siegel & Walmsley fully exited FLIR Systems, Inc. (DE) Common Stock in Q2 2021, selling an estimated $38.5M.
  • Thompson Siegel & Walmsley's ten largest holdings make up 17% of its $7.3B portfolio in Q2 2021.
  • Thompson Siegel & Walmsley opened 58 new positions and closed 72 in Q2 2021.
  • Thompson Siegel & Walmsley's portfolio value rose 4.2% quarter-over-quarter to $7.3B.

Based on Thompson Siegel & Walmsley's 13F filing for Q2 2021, filed 9 Aug 2021.